Abstract

With the advent of cancer immunology, mass cytometry has been increasingly employed to characterize the responses to cancer therapies and the tumor microenvironment (TME). One of its most notable applications is efficient multiplexing of samples into batches by dedicating a number of metal isotope channels to barcodes, enabling robust data acquisition and analysis. Barcoding is most effective when markers are present in all cells of interest. While CD45 has been shown to be a reliable marker for barcoding all immune cells in a given sample, a strategy to reliably barcode mouse cancer cells has not been demonstrated. To this end, we identified CD29 and CD98 as markers widely expressed by commonly used mouse cancer cell lines. We conjugated anti-CD29 and anti-CD98 antibodies to cadmium or indium metals and validated their utility in 10-plex barcoding of live cells. Finally, we established a potentially novel barcoding system incorporating the combination of CD29, CD98, and CD45 to multiplex 10 tumors from s.c. MC38 and KPC tumor models, while successfully recapitulating the known contrast in the PD1-PDL1 axis between the 2 models. The ability to barcode tumor cells along with immune cells empowers the interrogation of the tumor-immune interactions in mouse TME studies.

Highlights

  • With remarkable progress in cancer immunology, mass cytometry or cytometry by TOF (CyTOF) have increasingly contributed to the understanding of the tumor microenvironment (TME) [1, 2]

  • We found CD29 and CD98 as potential candidates, since they are detectable in all 31 different mouse cell lines within the database (Figure 1 and Supplemental Table 1)

  • CD29 is a surface marker involved in cell adhesion [11], while CD98 is a transmembrane protein involved in amino acid transport [12], and both are highly expressed in mouse CD45– stromal cell types (ImmGen, Supplemental Table 2)

Read more

Summary

Introduction

With remarkable progress in cancer immunology, mass cytometry or cytometry by TOF (CyTOF) have increasingly contributed to the understanding of the tumor microenvironment (TME) [1, 2]. CyTOF is a technique that allows multiparametric analysis of single cells using metal tagged antibodies [3]. Similar to flow cytometry, CyTOF employs the use of antibodies conjugated to heavy metal ions rather than fluorophores. This strategy overcomes problematic spectra overlap inherent to fluorophores, allowing the parametrization of 40 or more markers per cell [4]. CyTOF obviates technical vulnerabilities associated with tandem fluorophores and issues related to autofluorescence, which often complicate the flow cytometry applications in studying epithelial/cancer cells, myeloid cells, abundance of debris, or intracellular markers [4]. Barcoding improves throughput of data acquisition, reduces sample-to-sample variations, and provides a much more robust downstream analysis [5]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call